Skip to main content

Advertisement

SpringerLink
Log in

Further Validation of the IBS-QOL: Female Mexican IBS Patients Have Poorer Quality of Life Than Females from North Carolina

  • ORIGINAL Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The Irritable Bowel Syndrome (IBS)-Quality of Life (QOL) is the most extensively validated health-related quality of life (HRQOL)-specific instrument for IBS with appropriate evidence for psychometric validity. Our aim was to linguistically validate the IBS-QOL for Mexico according to standard guidelines, to conduct further psychometric validation, and to compare the HRQOL between IBS patients from Mexico and North Carolina (University of North Carolina). Construct validity was tested by correlating scores from the Mexican Spanish IBS-QOL with those for anxiety and depression obtained by the Hospital Anxiety and Depression scale. Also, HRQOL from Rome I female IBS patients who consulted a tertiary referral center in Mexico was compared with that of female patients from UNC matched by age and bowel habit. A general univariate linear model was done to determine the most important variable over HRQOL, place of origin, or bowel habit. The majority of the IBS-QOL items had a negative correlation with depression as well as with anxiety. Compared to patients from UNC, the Mexican ones reported significant lower scores on Body Image and Health Worry and a trend in Interference with activities and in the Overall score. There were some differences in Dysphoria and Interference that were related to bowel habit, independently of the place of origin. In conclusion, the IBS-QOL validated in Mexican Spanish has shown construct validity. Using this instrument we found that female IBS patients who consulted a tertiary referral center in Mexico have lower HRQOL than those in North Carolina at least in factors such as Body Image and Health Worry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835–840

    Article  PubMed  CAS  Google Scholar 

  2. Eisen GM, Locke GR III, Provenzale D (1999) Health-related quality of life: a primer for the gastroenterologists. Am J Gastroenterol 94:2017–2021

    Article  PubMed  CAS  Google Scholar 

  3. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119:654–660

    Article  PubMed  CAS  Google Scholar 

  4. Schmulson M, Robles G, Kershenobich D, López RR, Hinojosa CA, Duarte CA, Bandera J (2000) Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev Gastroenterol Méx 65 (Suppl 1):50

    Google Scholar 

  5. Chang L (2004) Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7):31–39

    Article  PubMed  CAS  Google Scholar 

  6. Patrick DL, Drossman D, Frederick IO, Dicesare J, Puder KL (1998) Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 43:400–411

    Article  PubMed  CAS  Google Scholar 

  7. Drossman DA, Patrick DL, Whitehead WE, Toner BD, Diamant NE, Hu Y, Jia H, Bangdiwala SI (2000) Am J Gastroenterol 95:999–1007

    Google Scholar 

  8. Acquadro C, Conway K, Giroudet C, Mear I (2004) Linguistic validation manual for patient-reported outcomes (PRO) instruments. MAPI Research Institute, Lyons, France

  9. Bijkerk CJ, de Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122–127

    Article  PubMed  CAS  Google Scholar 

  10. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  11. López-Alvarenga JC, Vzquez-Velzquez V, Arcila-Martínez D, Sierra-Ovando AE, Gonzles-Barranco J, Salín-Pascual RJ (2002) Exactitud y utilidad diagnóstica del Hospital Anxiety and Depresión Scale (HAD) en una muestra de sujetos obesos mexicanos. Rev Invest Clin 54:403–409

    PubMed  Google Scholar 

  12. Thompson WG, Working Team for Functional Bowel Disorders (1994) Functional bowel disorders and functional abdominal pain. In: The functional gastrointestinal disorders. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Little, Brown, Boston, pp 115–173

    Google Scholar 

  13. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternative. Gastroenterology 128:580–589

    Article  PubMed  Google Scholar 

  14. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002) Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97(Suppl):S1–S5

    Google Scholar 

  15. Bergman JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg 83(Suppl 5):87–91

    Google Scholar 

  16. Zuniga MA, Carrillo-Jimenez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118

    PubMed  CAS  Google Scholar 

  17. Schmulson M, Ortiz O, Hinojosa C, Arcila D (2006) A single session of reassurance can acutely improve the self-perception of impairment in patients with IBS. J Psychosom Res (in press)

  18. Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67–71

    Article  PubMed  CAS  Google Scholar 

  19. Badia X, Mearin F, Balboa A (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20:749–758

    Article  PubMed  Google Scholar 

  20. Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (2004) Impact of functional gastrointestinal disorders on health related quality of life: a population-based case-control study. Aliment Pharmacol Ther 19:233–242

    Article  PubMed  CAS  Google Scholar 

  21. Frank L., Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C (2002) Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24:675–689

    Article  PubMed  Google Scholar 

  22. Kellow J, Lee OY, Chang FY, Thongsawat S, Mazlam MZ, Yuen H, Gwee KA, Bak YT, Jones J, Wagner A (2003) An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671–676

    Article  PubMed  CAS  Google Scholar 

  23. Schmulson M, Remes JM, Olivas T, Valdovinos MA, Hinojosa C, Chang L, Mayer E, Naliboff B (2003) Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different? Gastroenterology 124 (Suppl 1):A-395

    Google Scholar 

  24. Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life. Is quality of life determined by expectations or experience? BMJ 322:1240–1243

    Article  PubMed  CAS  Google Scholar 

  25. Park MI, Camilleri M (2005) Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 34:305–317

    Article  PubMed  Google Scholar 

  26. Hahn BA, Ya S, Strassels S (1999) Impact of irritable bowel syndrome in the United States and United Kingdom. Digestion 60:77–81

    Google Scholar 

Download references

Acknowledgment

We thank MAPI Research Institute for all their support in the validation process of the IBS-QOL for Mexico.

Author information

Authors and Affiliations

  1. Laboratory of Liver, Pancreas and Motility (HIPAM), Department of Experimental Medicine, Faculty of Medicine, Universidad Nacional Autonoma de México (UNAM), Mexico City, Mexico

    Max Schmulson & Gabriela Gutierrez-Reyes

  2. Department of Internal Medicine, Centro Medico Nacional Siglo XXI, Mexico City, Mexico

    Orianna Ortiz

  3. Unit of Clinical Epidemiology, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, Mexico City, Mexico

    Juan Manuel Mejia-Arangure

  4. Division of Gastroenterology and Hepatology, UNC Center for Functional GI and Motility Disorders, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

    Yuming B. Hu, Carolyn Morris, Shrikant Bangdiwala & Douglas A. Drossman

  5. Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Denise Arcila

  6. Departamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autonoma de México (UNAM), Hospital General de México. Doctor Balmis 148, Colonia Doctores, C.P. 06726, Del Cuauhtemoc, Mexico City, Mexico

    Max Schmulson

Authors
  1. Max Schmulson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Orianna Ortiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Manuel Mejia-Arangure
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuming B. Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carolyn Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Denise Arcila
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriela Gutierrez-Reyes
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shrikant Bangdiwala
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Douglas A. Drossman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Max Schmulson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmulson, M., Ortiz, O., Mejia-Arangure, J.M. et al. Further Validation of the IBS-QOL: Female Mexican IBS Patients Have Poorer Quality of Life Than Females from North Carolina. Dig Dis Sci 52, 2950–2955 (2007). https://doi.org/10.1007/s10620-006-9689-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9689-9

Keywords

Search

Navigation